These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7041358

  • 1. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
    Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, LaQuaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS.
    Transplantation; 1981 Dec; 32(6):535-9. PubMed ID: 7041358
    [Abstract] [Full Text] [Related]

  • 2. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
    Thistlethwaite JR, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS.
    Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR, Barry JM, Alexander SR, Melvin T, Striegel J, Reller K, Henell KR, Kimball J, Funnell MB, Goldstein G.
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH, Lucas BA, Amlot P, Janossy G, Yacoub M, Cammisuli S, Jezek D, Rhoades J, Brown S, Thompson JS.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring immunosuppression following renal transplantation.
    Giorgi JV, Cosimi AB, Colvin RB, Goldstein G, Delmonico FL, Russell PS.
    Diagn Immunol; 1983 Nov; 1(3):174-8. PubMed ID: 6388969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
    Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS.
    N Engl J Med; 1981 Aug 06; 305(6):308-14. PubMed ID: 6454075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
    Chatenoud L, Bach JF.
    Nephrologie; 1987 Aug 06; 8(3):95-8. PubMed ID: 3309702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov 06; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.